Sopharma AD (BUL:SFA)
Bulgaria · Delayed Price · Currency is BGN · Price in EUR 1.930
-0.010 (-0.52%)
At close: Jun 19, 2026
Sopharma AD Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 80.63 | 68.3 | 39.12 | 49.07 | 36.36 | 45.77 |
Depreciation & Amortization | 40.54 | 38.07 | 28.27 | 26.62 | 24.98 | 25.89 |
Other Amortization | 2.4 | 2.35 | 2.15 | 1.99 | 1.72 | 1.37 |
Asset Writedown & Restructuring Costs | 0.15 | 0.15 | 0.13 | - | - | - |
Other Operating Activities | -81.19 | -99.39 | -30.34 | -54.66 | -6.78 | -111.86 |
Operating Cash Flow | 42.54 | 9.49 | 39.33 | 23.02 | 56.27 | -38.85 |
Operating Cash Flow Growth | -59.05% | -75.87% | 70.83% | -59.09% | - | - |
Capital Expenditures | -23.14 | -23.02 | -17.37 | -12.47 | -9.89 | -10.41 |
Sale of Property, Plant & Equipment | 0.76 | 0.65 | 1.47 | 7.68 | 0.98 | 0.54 |
Cash Acquisitions | -0.61 | -0.67 | -7.47 | -4.78 | -1.2 | -1.2 |
Divestitures | 5.78 | 5.67 | -0.12 | - | 0.2 | -0.59 |
Sale (Purchase) of Intangibles | -54.55 | -50.05 | -44.86 | -9.66 | -2.2 | -3.46 |
Sale (Purchase) of Real Estate | 0.18 | 0.18 | - | - | - | 1 |
Investment in Securities | 4.23 | 2.46 | -4.01 | -19.4 | -8.45 | -20.91 |
Other Investing Activities | -0.28 | -0.17 | 29.79 | 8.9 | -10.96 | -1.2 |
Investing Cash Flow | -64.26 | -61.72 | -45.16 | -32.13 | -32.51 | -34.81 |
Short-Term Debt Issued | - | 60.53 | 17.62 | 22.53 | 15.83 | 109.16 |
Long-Term Debt Issued | - | 22 | 73.51 | 18.69 | 1.11 | 8.61 |
Total Debt Issued | 55.5 | 82.54 | 91.13 | 41.23 | 16.93 | 117.76 |
Short-Term Debt Repaid | - | -3.31 | -17.51 | -0.61 | -30.2 | -13.88 |
Long-Term Debt Repaid | - | -33.08 | -45.52 | -15.51 | -18.46 | -20.39 |
Total Debt Repaid | -54.69 | -36.39 | -63.03 | -16.12 | -48.65 | -34.28 |
Net Debt Issued (Repaid) | 0.81 | 46.15 | 28.1 | 25.11 | -31.72 | 83.49 |
Issuance of Common Stock | 37.93 | 33.53 | 16.73 | 79.8 | - | - |
Repurchase of Common Stock | -0 | -0 | -0 | -2.69 | -0.98 | -8.5 |
Common Dividends Paid | -22.96 | -6.96 | -86.34 | -36.76 | -0.01 | -0.03 |
Other Financing Activities | 1.75 | -2.09 | -0.46 | -0.62 | -0.18 | 5.13 |
Financing Cash Flow | 17.53 | 70.63 | -41.97 | 64.85 | -32.89 | 80.08 |
Net Cash Flow | -4.19 | 18.4 | -47.8 | 55.74 | -9.13 | 6.43 |
Free Cash Flow | 19.4 | -13.53 | 21.96 | 10.55 | 46.38 | -49.25 |
Free Cash Flow Growth | -77.42% | - | 108.11% | -77.25% | - | - |
Free Cash Flow Margin | 1.38% | -1.00% | 1.99% | 1.09% | 5.43% | -5.98% |
Free Cash Flow Per Share | 0.04 | -0.04 | 0.04 | 0.03 | 0.12 | -0.13 |
Cash Interest Paid | 10.09 | 9.91 | 7.59 | 5.42 | 3.27 | 4.69 |
Cash Income Tax Paid | 62.82 | 61.69 | 37.51 | 6.86 | 5.04 | 4.04 |
Levered Free Cash Flow | - | -93.12 | -61.37 | 63.02 | 53.04 | 43.55 |
Unlevered Free Cash Flow | - | -86.25 | -57.23 | 66.53 | 54.96 | 47 |